Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 251

1.

Intradialytic creatine supplementation: A scientific rationale for improving the health and quality of life of dialysis patients.

Wallimann T, Riek U, Möddel M.

Med Hypotheses. 2017 Feb;99:1-14. doi: 10.1016/j.mehy.2016.12.002. Epub 2016 Dec 7. Review.

2.

Creatine: a miserable life without it.

Wallimann T, Harris R.

Amino Acids. 2016 Aug;48(8):1739-50. doi: 10.1007/s00726-016-2297-x. No abstract available.

PMID:
27422546
3.

Creatine supplementation improves neural progenitor cell survival in Huntington's disease.

Andres RH, Wallimann T, Widmer HR.

Brain Circ. 2016 Jul-Sep;2(3):133-137. doi: 10.4103/2394-8108.192519. Epub 2016 Oct 18. Review.

4.

The effects of creatine supplementation on striatal neural progenitor cells depend on developmental stage.

Andres RH, Ducray AD, Andereggen L, Hohl T, Schlattner U, Wallimann T, Widmer HR.

Amino Acids. 2016 Aug;48(8):1913-27. doi: 10.1007/s00726-016-2238-8. Epub 2016 Apr 29.

PMID:
27129463
5.

The extended, dynamic mitochondrial reticulum in skeletal muscle and the creatine kinase (CK)/phosphocreatine (PCr) shuttle are working hand in hand for optimal energy provision.

Wallimann T.

J Muscle Res Cell Motil. 2015 Oct;36(4-5):297-300. doi: 10.1007/s10974-015-9427-z. Epub 2015 Oct 20. No abstract available.

PMID:
26481241
6.

Modular organization of cardiac energy metabolism: energy conversion, transfer and feedback regulation.

Guzun R, Kaambre T, Bagur R, Grichine A, Usson Y, Varikmaa M, Anmann T, Tepp K, Timohhina N, Shevchuk I, Chekulayev V, Boucher F, Dos Santos P, Schlattner U, Wallimann T, Kuznetsov AV, Dzeja P, Aliev M, Saks V.

Acta Physiol (Oxf). 2015 Jan;213(1):84-106. doi: 10.1111/apha.12287. Epub 2014 Apr 18. Review.

7.

Comment on "toxic hepatitis in a group of 20 male body-builders taking dietary supplements" by.

Wallimann T.

Food Chem Toxicol. 2013 Jan;51:453-4. doi: 10.1016/j.fct.2012.10.022. Epub 2012 Oct 26. No abstract available.

PMID:
23108213
8.

Phosphocreatine interacts with phospholipids, affects membrane properties and exerts membrane-protective effects.

Tokarska-Schlattner M, Epand RF, Meiler F, Zandomeneghi G, Neumann D, Widmer HR, Meier BH, Epand RM, Saks V, Wallimann T, Schlattner U.

PLoS One. 2012;7(8):e43178. doi: 10.1371/journal.pone.0043178. Epub 2012 Aug 17.

9.

Molecular system bioenergics of the heart: experimental studies of metabolic compartmentation and energy fluxes versus computer modeling.

Aliev M, Guzun R, Karu-Varikmaa M, Kaambre T, Wallimann T, Saks V.

Int J Mol Sci. 2011;12(12):9296-331. doi: 10.3390/ijms12129296. Epub 2011 Dec 13. Review.

10.

A short review on creatine-creatine kinase system in relation to cancer and some experimental results on creatine as adjuvant in cancer therapy.

Patra S, Ghosh A, Roy SS, Bera S, Das M, Talukdar D, Ray S, Wallimann T, Ray M.

Amino Acids. 2012 Jun;42(6):2319-30. doi: 10.1007/s00726-011-0974-3. Epub 2011 Jul 19. Review.

PMID:
21769499
11.

The creatine kinase system and pleiotropic effects of creatine.

Wallimann T, Tokarska-Schlattner M, Schlattner U.

Amino Acids. 2011 May;40(5):1271-96. doi: 10.1007/s00726-011-0877-3. Epub 2011 Mar 30. Review.

12.

Where have the fluxes gone?

Aliev M, Schlattner U, Dzeja P, Wallimann T, Saks V.

J Biol Chem. 2010 Dec 24;285(52):le21; author reply le22. doi: 10.1074/jbc.L110.147116. No abstract available.

13.

Regulation of the creatine transporter by AMP-activated protein kinase in kidney epithelial cells.

Li H, Thali RF, Smolak C, Gong F, Alzamora R, Wallimann T, Scholz R, Pastor-Soler NM, Neumann D, Hallows KR.

Am J Physiol Renal Physiol. 2010 Jul;299(1):F167-77. doi: 10.1152/ajprenal.00162.2010. Epub 2010 May 12.

14.

Creatine kinases: a cornerstone for structural research in the phosphagen kinase family.

Wallimann T, Schlattner U.

FASEB J. 2010 Jan;24(1):7. doi: 10.1096/fj.10-0102ufm. No abstract available.

PMID:
20047896
15.

PKA phosphorylates and inactivates AMPKalpha to promote efficient lipolysis.

Djouder N, Tuerk RD, Suter M, Salvioni P, Thali RF, Scholz R, Vaahtomeri K, Auchli Y, Rechsteiner H, Brunisholz RA, Viollet B, Mäkelä TP, Wallimann T, Neumann D, Krek W.

EMBO J. 2010 Jan 20;29(2):469-81. doi: 10.1038/emboj.2009.339. Epub 2009 Nov 26.

16.

Homo-oligomerization and activation of AMP-activated protein kinase are mediated by the kinase domain alphaG-helix.

Scholz R, Suter M, Weimann T, Polge C, Konarev PV, Thali RF, Tuerk RD, Viollet B, Wallimann T, Schlattner U, Neumann D.

J Biol Chem. 2009 Oct 2;284(40):27425-37. doi: 10.1074/jbc.M109.047670. Epub 2009 Aug 3.

17.

Developmental changes in the expression of creatine synthesizing enzymes and creatine transporter in a precocial rodent, the spiny mouse.

Ireland Z, Russell AP, Wallimann T, Walker DW, Snow R.

BMC Dev Biol. 2009 Jul 1;9:39. doi: 10.1186/1471-213X-9-39.

18.

Development and performance of an enzyme immunoassay to detect creatine kinase isoenzyme MB activity using anti-mitochondrial creatine kinase monoclonal antibodies.

Hoshino T, Sakai Y, Yamashita K, Shirahase Y, Sakaguchi K, Asaeda A, Kishi K, Schlattner U, Wallimann T, Yanai M, Kumasaka K.

Scand J Clin Lab Invest. 2009;69(6):687-95. doi: 10.3109/00365510902981171.

PMID:
19484658
19.

A versatile multidimensional protein purification system with full internet remote control based on a standard HPLC system.

Riek U, Ramirez S, Wallimann T, Schlattner U.

Biotechniques. 2009 May;46(6):ix-xii. doi: 10.2144/000113130.

20.

Tracking and quantification of 32P-labeled phosphopeptides in liquid chromatography matrix-assisted laser desorption/ionization mass spectrometry.

Tuerk RD, Auchli Y, Thali RF, Scholz R, Wallimann T, Brunisholz RA, Neumann D.

Anal Biochem. 2009 Jul 15;390(2):141-8. doi: 10.1016/j.ab.2009.04.015. Epub 2009 Apr 17.

PMID:
19376078
21.

Metabolic compartmentation - a system level property of muscle cells: real problems of diffusion in living cells.

Saks V, Beraud N, Wallimann T.

Int J Mol Sci. 2008 May;9(5):751-67. doi: 10.3390/ijms9050751. Epub 2008 May 9.

22.

Enzymes of creatine biosynthesis, arginine and methionine metabolism in normal and malignant cells.

Bera S, Wallimann T, Ray S, Ray M.

FEBS J. 2008 Dec;275(23):5899-909. doi: 10.1111/j.1742-4658.2008.06718.x.

23.

An automated home-built low-cost fermenter suitable for large-scale bacterial expression of proteins in Escherichia coli.

Riek U, Tuerk R, Wallimann T, Schlattner U, Neumann D.

Biotechniques. 2008 Aug;45(2):187-9. doi: 10.2144/000112830.

24.

Creatine and creatine kinase in health and disease--a bright future ahead?

Wyss M, Braissant O, Pischel I, Salomons GS, Schulze A, Stockler S, Wallimann T.

Subcell Biochem. 2007;46:309-34. Review.

PMID:
18652084
25.

The creatine kinase phosphotransfer network: thermodynamic and kinetic considerations, the impact of the mitochondrial outer membrane and modelling approaches.

Saks V, Kaambre T, Guzun R, Anmann T, Sikk P, Schlattner U, Wallimann T, Aliev M, Vendelin M.

Subcell Biochem. 2007;46:27-65. Review.

PMID:
18652071
26.

Introduction--creatine: cheap ergogenic supplement with great potential for health and disease.

Wallimann T.

Subcell Biochem. 2007;46:1-16. No abstract available.

PMID:
18652069
27.

European research needs a dash of anarchy.

Wallimann T.

Nature. 2008 Jun 12;453(7197):850. doi: 10.1038/453850c. No abstract available.

PMID:
18548046
28.

Functions and effects of creatine in the central nervous system.

Andres RH, Ducray AD, Schlattner U, Wallimann T, Widmer HR.

Brain Res Bull. 2008 Jul 1;76(4):329-43. doi: 10.1016/j.brainresbull.2008.02.035. Epub 2008 Mar 24. Review.

PMID:
18502307
29.

Progressive decrease of phosphocreatine, creatine and creatine kinase in skeletal muscle upon transformation to sarcoma.

Patra S, Bera S, SinhaRoy S, Ghoshal S, Ray S, Basu A, Schlattner U, Wallimann T, Ray M.

FEBS J. 2008 Jun;275(12):3236-47. doi: 10.1111/j.1742-4658.2008.06475.x. Epub 2008 May 13.

30.

Dietary phytoestrogens activate AMP-activated protein kinase with improvement in lipid and glucose metabolism.

Cederroth CR, Vinciguerra M, Gjinovci A, Kühne F, Klein M, Cederroth M, Caille D, Suter M, Neumann D, James RW, Doerge DR, Wallimann T, Meda P, Foti M, Rohner-Jeanrenaud F, Vassalli JD, Nef S.

Diabetes. 2008 May;57(5):1176-85. doi: 10.2337/db07-0630. Epub 2008 Apr 16.

31.

Ammonium alters creatine transport and synthesis in a 3D culture of developing brain cells, resulting in secondary cerebral creatine deficiency.

Braissant O, Cagnon L, Monnet-Tschudi F, Speer O, Wallimann T, Honegger P, Henry H.

Eur J Neurosci. 2008 Apr;27(7):1673-85. doi: 10.1111/j.1460-9568.2008.06126.x.

PMID:
18380667
32.

Structural properties of AMP-activated protein kinase: dimerization, molecular shape, and changes upon ligand binding.

Riek U, Scholz R, Konarev P, Rufer A, Suter M, Nazabal A, Ringler P, Chami M, Müller SA, Neumann D, Forstner M, Hennig M, Zenobi R, Engel A, Svergun D, Schlattner U, Wallimann T.

J Biol Chem. 2008 Jun 27;283(26):18331-43. doi: 10.1074/jbc.M708379200. Epub 2008 Mar 27.

33.

Reduced creatine-stimulated respiration in doxorubicin challenged mitochondria: particular sensitivity of the heart.

Tokarska-Schlattner M, Dolder M, Gerber I, Speer O, Wallimann T, Schlattner U.

Biochim Biophys Acta. 2007 Nov;1767(11):1276-84. Epub 2007 Sep 8.

34.

Co-expression of LKB1, MO25alpha and STRADalpha in bacteria yield the functional and active heterotrimeric complex.

Neumann D, Suter M, Tuerk R, Riek U, Wallimann T.

Mol Biotechnol. 2007 Jul;36(3):220-31.

PMID:
17873408
35.

Inhibition of cytosolic and mitochondrial creatine kinase by siRNA in HaCaT- and HeLaS3-cells affects cell viability and mitochondrial morphology.

Lenz H, Schmidt M, Welge V, Kueper T, Schlattner U, Wallimann T, Elsässer HP, Wittern KP, Wenck H, Staeb F, Blatt T.

Mol Cell Biochem. 2007 Dec;306(1-2):153-62. Epub 2007 Jul 28.

PMID:
17660950
36.

New candidate targets of AMP-activated protein kinase in murine brain revealed by a novel multidimensional substrate-screen for protein kinases.

Tuerk RD, Thali RF, Auchli Y, Rechsteiner H, Brunisholz RA, Schlattner U, Wallimann T, Neumann D.

J Proteome Res. 2007 Aug;6(8):3266-77. Epub 2007 Jul 4.

PMID:
17608512
37.

Creatine treatment promotes differentiation of GABA-ergic neuronal precursors in cultured fetal rat spinal cord.

Ducray AD, Schläppi JA, Qualls R, Andres RH, Seiler RW, Schlattner U, Wallimann T, Widmer HR.

J Neurosci Res. 2007 Jul;85(9):1863-75.

PMID:
17526013
38.

Macroenzyme creatine kinase (CK) type 2 in HIV-infected patients is significantly associated with TDF and consists of ubiquitous mitochondrial CK.

Schmid H, Mühlbayer D, Röling J, Sternfeld T, Jülg B, Schlattner U, Nelson PJ, Bogner JR, Wallimann T, Goebel FD.

Antivir Ther. 2006;11(8):1071-80.

PMID:
17302377
39.

Hair bundles are specialized for ATP delivery via creatine kinase.

Shin JB, Streijger F, Beynon A, Peters T, Gadzala L, McMillen D, Bystrom C, Van der Zee CE, Wallimann T, Gillespie PG.

Neuron. 2007 Feb 1;53(3):371-86.

40.

Creatine promotes the GABAergic phenotype in human fetal spinal cord cultures.

Ducray AD, Qualls R, Schlattner U, Andres RH, Dreher E, Seiler RW, Wallimann T, Widmer HR.

Brain Res. 2007 Mar 16;1137(1):50-7. Epub 2006 Dec 20.

PMID:
17223088
41.

Cardiolipin clusters and membrane domain formation induced by mitochondrial proteins.

Epand RF, Tokarska-Schlattner M, Schlattner U, Wallimann T, Epand RM.

J Mol Biol. 2007 Jan 26;365(4):968-80. Epub 2006 Oct 13.

PMID:
17097675
42.

The creatine kinase/creatine connection to Alzheimer's disease: CK-inactivation, APP-CK complexes and focal creatine deposits.

Bürklen TS, Schlattner U, Homayouni R, Gough K, Rak M, Szeghalmi A, Wallimann T.

J Biomed Biotechnol. 2006;2006(3):35936.

43.

Brain-type creatine kinase BB-CK interacts with the Golgi Matrix Protein GM130 in early prophase.

Bürklen TS, Hirschy A, Wallimann T.

Mol Cell Biochem. 2007 Mar;297(1-2):53-64. Epub 2006 Oct 12.

PMID:
17036164
44.

Novel lipid transfer property of two mitochondrial proteins that bridge the inner and outer membranes.

Epand RF, Schlattner U, Wallimann T, Lacombe ML, Epand RM.

Biophys J. 2007 Jan 1;92(1):126-37. Epub 2006 Oct 6.

45.

Molecular system bioenergetics: regulation of substrate supply in response to heart energy demands.

Saks V, Favier R, Guzun R, Schlattner U, Wallimann T.

J Physiol. 2006 Dec 15;577(Pt 3):769-77. Epub 2006 Sep 28. Review.

46.

Alterations in myocardial energy metabolism induced by the anti-cancer drug doxorubicin.

Tokarska-Schlattner M, Wallimann T, Schlattner U.

C R Biol. 2006 Sep;329(9):657-68. Epub 2006 Jun 21. Review.

PMID:
16945832
47.

Dissecting the role of 5'-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase.

Suter M, Riek U, Tuerk R, Schlattner U, Wallimann T, Neumann D.

J Biol Chem. 2006 Oct 27;281(43):32207-16. Epub 2006 Aug 30.

48.

New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics.

Tokarska-Schlattner M, Zaugg M, Zuppinger C, Wallimann T, Schlattner U.

J Mol Cell Cardiol. 2006 Sep;41(3):389-405. Epub 2006 Aug 1. Review.

PMID:
16879835
49.

AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits.

Treebak JT, Glund S, Deshmukh A, Klein DK, Long YC, Jensen TE, Jørgensen SB, Viollet B, Andersson L, Neumann D, Wallimann T, Richter EA, Chibalin AV, Zierath JR, Wojtaszewski JF.

Diabetes. 2006 Jul;55(7):2051-8.

50.

Improved reperfusion and neuroprotection by creatine in a mouse model of stroke.

Prass K, Royl G, Lindauer U, Freyer D, Megow D, Dirnagl U, Stöckler-Ipsiroglu G, Wallimann T, Priller J.

J Cereb Blood Flow Metab. 2007 Mar;27(3):452-9. Epub 2006 Jun 14. Erratum in: J Cereb Blood Flow Metab. 2007 Jun;27(6):1290.

PMID:
16773141

Supplemental Content

Loading ...
Support Center